| Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis DW Kurniawan, AK Jajoriya, G Dhawan, D Mishra, J Argemi, R Bataller, ... Journal of controlled release 288, 227-238, 2018 | 52 | 2018 |
| Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease N Fujiwara, N Kubota, E Crouchet, B Koneru, CA Marquez, AK Jajoriya, ... Science translational medicine 14 (650), eabo4474, 2022 | 47 | 2022 |
| Click biotinylation of PLGA template for biotin receptor oriented delivery of doxorubicin hydrochloride in 4T1 cell-induced breast cancer Y Singh, KK Durga Rao Viswanadham, A Kumar Jajoriya, JG Meher, ... Molecular pharmaceutics 14 (8), 2749-2765, 2017 | 28 | 2017 |
| P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel G Pandey, N Mittapelly, GR Valicherla, RP Shukla, S Sharma, VT Banala, ... Colloids and Surfaces B: Biointerfaces 155, 276-286, 2017 | 25 | 2017 |
| Molecular signature predictive of long-term liver fibrosis progression to inform antifibrotic drug development T Qian, N Fujiwara, B Koneru, A Ono, N Kubota, AK Jajoriya, MG Tung, ... Gastroenterology 162 (4), 1210-1225, 2022 | 18 | 2022 |
| Induction of mitochondrial cell death and reversal of anticancer drug resistance via nanocarriers composed of a triphenylphosphonium derivative of tocopheryl polyethylene … Y Singh, KKDR Viswanadham, VK Pawar, J Meher, AK Jajoriya, A Omer, ... Molecular Pharmaceutics 16 (9), 3744-3759, 2019 | 10 | 2019 |
| Protocol Handbook for Cancer Biology G Misra, J Rajawat Academic Press, 2021 | 2 | 2021 |
| Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis DW Kurniawan, R Booijink, AK Jajoriya, G Dhawan, D Mishra, ... Clinical and Translational Discovery 2 (1), e18, 2022 | 1 | 2022 |
| PHARMACOLOGICAL INHIBITION OF INDOLEAMINE 2, 3-DIOXYGENASE (IDO1) FOR IMMUNOPREVENTION OF NAFLD-RELATED HCC SK Mishra, S Paul, H Suzuki, AK Jajoriya, N Kubota, A Hassan, C Katz, ... HEPATOLOGY 78, S1947-S1948, 2023 | | 2023 |
| PHARMACOLOGICAL INHIBITION OF DISCOIDIN DOMAIN RECEPTOR TYROSINE KINASE 1 (DDR1) FOR HCC CHEMOPREVENTION AFTER HCV CURE C Katz, N Kubota, SK Mishra, S Paul, AK Jajoriya, A Hassan, CA Marquez, ... HEPATOLOGY 78, S102-S103, 2023 | | 2023 |
| MOLECULAR SUBTYPES OF NON-ALCOHOLIC FATTY LIVER DISEASE TO INFORM DISEASE PROGRESSION AND THERAPEUTIC DECISION MAKING N Fujiwara, A Jajoriya, N Kubota, CA Marquez, G Panda, T Qian, S Zhu, ... HEPATOLOGY 76, S681-S683, 2022 | | 2022 |
| High throughput cell-based screening methods for cancer drug discovery AK Jajoriya Protocol Handbook for Cancer Biology, 169-182, 2021 | | 2021 |
| Survivin aggravates fibrogenecity of hepatic stellate cells via mediating TGF-beta/PI3K/Akt pathway AK Jajoriya, J Bagga, A Nirwan, DP Mishra JOURNAL OF HEPATOLOGY 70, E194-E195, 2019 | | 2019 |
